Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 228

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Statins and risk of cancer: A systematic review and metaanalysis

Browning, Danielle R.L., Martin, Richard M.·2007·International Journal of Cancer

Abstract

We conducted a systematic review of the association between HMG‐CoA reductase inhibitor (statin) use and cancer risk. We searched MEDLINE, EMBASE, Web of Science, ISI Proceedings and BIOSIS Previews bibliographic databases, electronic trials registers and reference lists for potentially eligible randomized trials and observational studies. Thirty‐eight individual studies (26 randomized trials involving 103,573 participants and 12 observational studies with 826,854 participants) were included. Median follow‐up was 3.6 and 6.2 years for trials and observational studies, respectively. In metaanalyses of randomized trials, there was no evidence that statin therapy was associated with incidence of all‐cancers (26 trials; pooled risk ratio = 1.00; 95% CI 0.95–1.05; I2 = 0%) or the following site‐specific cancers: breast (7 trials; risk ratio = 1.01; 0.79–1.30; I2 = 43%), prostate (4 trials; risk ratio = 1.00; 0.85–1.17; I2 = 0%), colorectum (9 trials; risk ratio = 1.02; 0.89–1.16; I2 = 0%), lung (9 trials; risk ratio = 0.96; 0.84–1.09; I2 = 0%), genito‐urinary (5 trials; risk ratio = 0.95; 0.83–1.09; I2 = 0%), melanoma (4 trials; risk ratio = 0.86; 0.62–1.20; I2 = 17%) or gastric (1 trial; risk ratio = 1.00; 0.35–2.85). There was no evidence of differential effects by length of follow‐up, statin type (lipophilic vs. lipophobic) or potency. Trial results were generally consistent with observational studies. We conclude that statin use is not associated with short‐term cancer risk, but longer‐latency effects remain possible. © 2006 Wiley‐Liss, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ijc.22366

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

Metadata

Authors
Browning, D. R. L., & Martin, R. M.
Venue
International Journal of Cancer
Publisher
Wiley
Published
2006-12-27
Volume
120
Issue
4
Pages
833-843
ISSN
  • 0020-7136 (ISSN-L)
  • 1097-0215
OpenAlex
W2035095377
Cited by
228
References
12
FWCI
0.71
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.